Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Illumina Inc (NASDAQ: ILMN) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Illumina Inc (NASDAQ: ILMN) concerning whether a series of statements by Illumina Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On April 18, 2016, Illumina disclosed its preliminary first-quarter revenue. The Company stated it expects revenues of $572 million, lower than the $596 million originally forecast. The Company Chairman and CEO, Jay Flatley stated “Our first quarter results fell short of expectations largely due to lower than expected sales of HiSeq 2500, 3000 and 4000 instruments. Despite this slow start in Q1, we anticipate that our Americas and Asia Pacific regions will meet our expectations for the full year, but that Europe will underperform. As a result, we now project approximately 12% revenue growth for fiscal 2016”.

Following this news, NASDAQ: ILMN shares dropped more than 23% on April 19, 2016.

Based in San Diego, CA, and founded in 1998 Illumina Inc provides sequencing and array-based solutions for genetic analysis.

If you purchased shares of Illumina Inc (NASDAQ: ILMN) on or before April 18, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185